Despite advances in the diagnosis of prostate cancer over the past century, it remains a leading cause of cancer related death. A recent recommendation against screening has further complicated the diagnosis and management of this condition. It remains to be demonstrated if newer diagnostic modalities will have an impact on mortality rates. Most certainly, not all prostate cancers need to be diagnosed, and methods of accurately diagnosing those cancers that lead to death needs more work. In this review article, we describe the different techniques, approaches and diagnostic accuracies of the currently used biopsy methods.
Archivos espanoles de urologia. 2016 Jul [Epub]
B N Reddy, T Bessede, A Reddy, S Nair, A K Tewari, A R Rastinehad
Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA., Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA. U1195, Univ. Paris Sud. INSERM. Université Paris-Saclay. Le Kremlin-Bicetre. France. Department of Urology. Hopitaux Universitaires Paris-Sud. Le Kremlin-Bicetre. France., Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA., Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA., Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA., Department of Urology. Icahn School of Medicine at Mount Sinai. New York City. USA.